Lipotype Beats Nextcea Patent Suit Over Lipid Diagnostic Tests
Lipotype Inc. defeated Nextcea Inc.'s lawsuit claiming its lipid-analysis tests infringed a patented method for diagnosing certain medical conditions by using a specific biomarker after a federal court deemed the claims uninventive.


